(3DPrint.com PRO is offered solely to subscribers)
When the U.S. Meals and Drug Administration (FDA) permitted the world’s first 3D printed capsule in 2015, it marked a turning level in pharmaceutical manufacturing. The drug was Spritam, a fast-dissolving epilepsy treatment made by Aprecia Prescription drugs utilizing its binder-jetting ZipDose expertise. Almost a decade later, the thought of 3D printed capsules is not experimental. The expertise is taking form, even when it’s nonetheless removed from mainstream.
Whereas the sector stays small, many startups and pharmaceutical giants are actually utilizing 3D printing to reshape how medication are formulated, delivered, and distributed. From customized polypills and chewable tablets to drug-loaded implants and microneedle patches, the chances are increasing — and so is investor curiosity.
Already a subscriber?
You’re set to obtain premium content material on to your inbox twice a month.
